Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto
17th January 2025 Uncategorised 0The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto’s market exclusivity—took another zig on Thursday with a federal appellate court blocking the sale of a generic version of the heart failure blockbuster.
More: Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto
Source: fierce